Concomitant use of FSH and low-dose recombinant hCG during the late follicular phase versus conventional controlled ovarian stimulation for intracytoplasmic sperm injection cycles

References

• Aflatoonian, A., Yousefnejad, F., Eftekhar, M., & Mohammadian, F. (2012). Efficacy of low-dose hCG in late follicular phase in controlled ovarian stimulation using GnRH agonist protocol. Archives of Gynecology and Obstetrics, 286, 771–775. doi: 10.1007/s00404-012-2337-z.
   PubMed Web of Science ®Google Scholar
• Al-Inany, H.G., Youssef, M.A., Aboulghar, M., Broekmans, F., Sterrenburg, M., Smit, J., & Abou-Setta, A.M. (2011). Gonadotrophin-releasing hormone antagonists for assisted reproductive technology. Cochrane Database of Systematic Reviews, 2011, CD001750. doi: 10.1002/14651858.CD001750.pub3.
   PubMed Web of Science ®Google Scholar
• Bentov, Y., Kenigsberg, S., & Casper, R.F. (2012). A novel luteinizing hormone/chorionic gonadotropin receptor mutation associated with amenorrhea, low oocyte yield, and recurrent pregnancy loss. Fertility and Sterility, 97, 1165–1168. doi: 10.1016/j.fertnstert.2012.02.002.
   PubMed Web of Science ®Google Scholar
• Beretsos, P., Partsinevelos, G.A., Arabatzi, E., Drakakis, P., Mavrogianni, D., Anagnostou, E., … Loutradis, D. (2009). “hCG priming” effect in controlled ovarian stimulation through a long protocol. Reproductive Biology and Endocrinology, 7, 91. doi: 10.1186/1477-7827-7-91.
   PubMed Web of Science ®Google Scholar
• Berkkanoglu, M., Isikoglu, M., Aydin, D., & Ozgur, K. (2007). Clinical effects of ovulation induction with recombinant follicle-stimulating hormone supplemented with recombinant luteinizing hormone or low-dose recombinant human chorionic gonadotropin in the midfollicular phase in microdose cycles in poor responders. Fertility and Sterility, 88, 665–669. doi:10.1016/j.fertnstert.2006.11.150.
   PubMed Web of Science ®Google Scholar
• Blockeel, C., De Vos, M., Verpoest, W., Stoop, D., Haentjen, P., & Devroey, P. (2009). Can 200 IU of hCG replace recombinant FSH in the late follicular phase in a GnRH-antagonist cycle? A pilot study. Human Reproduction, 24, 2910–2916. doi: 10.1093/humrep/dep253.
   PubMed Web of Science ®Google Scholar
• Bosch, E., Labarta, E., Crespo, J., Simón, C., Remohí, J., Jenkins, J., & Pellicer, A. (2010). Circulating progesterone levels and ongoing pregnancy rates in controlled ovarian stimulation cycles for in vitro fertilization: analysis of over 4000 cycles. Human Reproduction, 25, 2092–2100. doi: 10.1093/humrep/deq125.
   PubMed Web of Science ®Google Scholar
• Bourgain, C., & Devroey, P. (2003). The endometrium in stimulated cycles for IVF. Human Reproduction Update, 9, 515–522. doi: 10.1093/humupd/dmg045.
   PubMed Web of Science ®Google Scholar
• Cavagna, M., Maldonado, L.G., de Souza Bonetti, T.C., de Almeida Ferreira Braga, D.P., Iaconelli, Jr., A., Borges., & Jr, E. (2010). Supplementation with a recombinant human chorionic gonadotropin microdose leads to similar outcomes in ovarian stimulation with recombinant follicle-stimulating hormone using either a gonadotropin-releasing hormone agonist or antagonist for pituitary suppression. Fertility and Sterility, 94, 167–172. doi: 10.1016/j.fertnstert.2009.02.075.
   PubMed Web of Science ®Google Scholar
• Coppola, F., Poti, E.R., Barusi, L., Ferrari, B., Salvarani, M.C., & Vadora, E. (2003). Profound luteinizing hormone suppression induces a deleterious follicular environment during assisted reproduction technology. Fertility and Sterility, 79, 459–460. doi: 10.1016/S0015-0282(02)04671-X.
   PubMed Web of Science ®Google Scholar
• De Placido, G., Alviggi, C., Perino, A., Strina, I., Lisi, F., Fasolino, A., … Mollo, A. Italian Collaborative Group on Recombinant Human Luteinizing Hormone. (2005). Recombinant human LH supplementation versus recombinant human FSH (rFSH) step-up protocol during controlled ovarian stimulation in normogonadotrophic women with initial inadequate ovarian response to rFSH. A multicentre, prospective, randomized controlled trial. Human Reproduction, 20, 390–396. doi: 10.1093/humrep/deh625.
   PubMed Web of Science ®Google Scholar
• Dominguez, F., Pellicer, A., & Simon, C. (2003). The chemokine connection: hormonal and embryonic regulation at the human maternal-embryonic interface–a review. Placenta, 24, S48–S55. doi: 10.1016/S0143-4004(03)00134-6.
   PubMed Web of Science ®Google Scholar
• Drakakis, P., Loutradis, D., Beloukas, A., Sypsa, V., Anastasiadou, V., Kalofolias, G., … Antsaklis, A. (2009). Early hCG addition to rFSH for ovarian stimulation in IVF provides better results and the cDNA copies of the hCG receptor may be an indicator of successful stimulation. Reproductive Biology and Endocrinology, 7, 110. doi: 10.1186/1477-7827-7-110.
   PubMed Web of Science ®Google Scholar
• Ebner, T., Yaman, C., Moser, M., Sommergruber, M., Feichtinger, O., & Tews, G. (2000). Prognostic value of first polar body morphology on fertilization rate and embryo quality in intracytoplasmic sperm injection. Human Reproduction, 15, 427–430. doi: 10.1093/humrep/15.2.427.
   PubMed Web of Science ®Google Scholar
• Fauser, B.C., & Devroey, P. (2003). Reproductive biology and IVF: ovarian stimulation and luteal phase consequences. Trends in Endocrinology and Metabolism, 14, 236–242. doi: 10.1016/S1043-2760(03)00075-4.
   PubMed Web of Science ®Google Scholar
• Fauser, B.C., & Van Heusden, A.M. (1997). Manipulation of human ovarian function: physiological concepts and clinical consequences. Endocrine Reviews, 18, 71–106. doi: 10.1210/edrv.18.1.0290.
   PubMed Web of Science ®Google Scholar
• Filicori, M., & Cognigni, G.E. (2001). Clinical review 126: Roles and novel regimens of luteinizing hormone and follicle-stimulating hormone in ovulation induction. Journal of Clinical Endocrinology and Metabolism, 86, 1437–1441. doi: 10.1210/jcem.86.4.7385.
   PubMed Web of Science ®Google Scholar
• Filicori, M., Cognigni, G.E., Gamberini, E., Parmegiani, L., Troilo, E., & Roset, B. (2005). Efficacy of low-dose human chorionic gonadotropin alone to complete controlled ovarian stimulation. Fertility and Sterility, 84, 394–401. doi: 10.1016/j.fertnstert.2005.02.036.
   PubMed Web of Science ®Google Scholar
• Filicori, M., Cognigni, G.E., Tabarelli, C., Pocognoli, P., Taraborrelli, S., Spettoli, D., & Ciampaglia, W. (2002a). Stimulation and growth of antral ovarian follicles by selective LH activity administration in women. Journal of Clinical Endocrinology and Metabolism, 87, 1156–1161. doi: 10.1210/jcem.87.3.8322.
   PubMed Web of Science ®Google Scholar
• Filicori, M., Cognigni, G.E., Taraborrelli, S., Parmegiani, L., Bernardi, S., & Ciampaglia, W. (2002b). Intracytoplasmic sperm injection pregnancy after low-dose human chorionic gonadotropin alone to support ovarian folliculogenesis. Fertility and Sterility, 78, 414–416. doi: 10.1016/S0015-0282(02)03243-0.
   PubMed Web of Science ®Google Scholar
• Filicori, M., Cognigni, G.E., Taraborrelli, S., Spettoli, D., Ciampaglia, W., & de Fatis, C.T. (1999a). Low-dose human chorionic gonadotropin therapy can improve sensitivity to exogenous follicle-stimulating hormone in patients with secondary amenorrhea. Fertility and Sterility, 72, 1118–1120. doi: 10.1016/S0015-0282(99)00426-4.
   PubMed Web of Science ®Google Scholar
• Filicori, M., Cognigni, G.E., Taraborrelli, S., Spettoli, D., Ciampaglia, W., de Fatis, C.T., & Pocognoli, P. (1999b). Luteinizing hormone activity supplementation enhances follicle-stimulating hormone efficacy and improves ovulation induction outcome. Journal of Clinical Endocrinology and Metabolism, 84, 2659–2663. doi: 10.1210/jcem.84.8.5884.
   PubMed Web of Science ®Google Scholar
• Filicori, M., Cognigni, G.E., Taraborrelli, S., Spettoli, D., Ciampaglia, W., Tabarelli, C., … Boschi, S. (2001). Luteinzing hormone activity in menotropins optimizes folliculogenesis and treatment in controlled ovarian stimulation. Journal of Clinical Endocrinology and Metabolism, 86, 337–343. doi: 10.1210/jcem.86.1.7108.
   PubMed Web of Science ®Google Scholar
• Fleming, R., Lloyd, F., Herbert, M., Fenwick, J., Griffiths, T., & Murdoch, A. (1998). Effects of profound suppression of luteinizing hormone during ovarian stimulation on follicular activity, oocyte and embryo function in cycles stimulated with purified follicle stimulating hormone. Human Reproduction, 13, 1788–1792. doi: 10.1093/humrep/13.7.1788.
   PubMed Web of Science ®Google Scholar
• Gomes, M.K., Vieira, C.S., Moura, M.D., Manetta, L.A., Leite, S.P., Reis, R.M., & Ferriani, R.A. (2007). Controlled ovarian stimulation with exclusive FSH followed by stimulation with hCG alone, FSH alone or hMG. European Journal of Obstetrics, Gynecology and Reproductive Biology, 130, 99–106. doi: 10.1016/j.ejogrb.2006.05.025.
   PubMed Web of Science ®Google Scholar
• Hamdine, O., Macklon, N.S., Eijkemans, M.J., Laven, J.S., Cohlen, B.J., Verhoeff, A., … Broekmans, F.J. CETRO trial study group. (2014). Elevated early follicular progesterone levels and in vitro fertilization outcomes: a prospective intervention study and meta-analysis. Fertility and Sterility, 102, 448–454.e1. doi: 10.1016/j.fertnstert.2014.05.002.
   PubMed Web of Science ®Google Scholar
• Inge, G.B., Brinsden, P.R., & Elder, K.T. (2005). Oocyte number per live birth in IVF: were Steptoe and Edwards less wasteful?. Human. Reproduction, 20, 588–592. doi: 10.1093/humrep/deh655.
   PubMed Web of Science ®Google Scholar
• Koichi, K., Yukiko, N., Shima, K., & Sachiko, S. (2006). Efficacy of low-dose human chorionic gonadotropin (hCG) in a GnRH antagonist protocol. Journal of Assisted Reproduction and Genetics, 23, 223–228. doi: 10.1007/s10815-006-9036-2.
   PubMed Web of Science ®Google Scholar
• Kovacs, P., Sajgo, A., Kaali, S.G., & Pal, L. (2012). Detrimental effects of high-dose gonadotropin on outcome of IVF: making a case for gentle ovarian stimulation strategies. Reproductive Sciences, 19, 718–724. doi: 10.1177/1933719111432859.
   PubMed Web of Science ®Google Scholar
• Lee, A., Miller, K., Elkinnd-Hirsch, K., & Scott, R. (2004). The “un-coast”— use of low-dose hCG alone to complete ovarian folliculogenesis in a high responder. Fertility and Sterility, 82, S120. doi: 10.1016/j.fertnstert.2004.07.304.
   PubMed Web of Science ®Google Scholar
• Macklon, N.S., Stouffer, R.L., Giudice, L.C., & Fauser, B.C. (2006). The science behind 25 years of ovarian stimulation for in vitro fertilization. Endocrine Reviews, 27, 170–207. doi: 10.1210/er.2005-0015.
   PubMed Web of Science ®Google Scholar
• Maldonado, L.G., Franco, J.G., Jr., Setti, A.S., Iaconelli, A., Jr., & Borges, E. Jr., (2013). Cost-effectiveness comparison between pituitary down-regulation with a gonadotropin-releasing hormone agonist short regimen on alternate days and an antagonist protocol for assisted fertilization treatments. Fertility and Sterility, 99, 1615–1622. doi: 10.1016/j.fertnstert.2013.01.095.
   PubMed Web of Science ®Google Scholar
• Martins, W.P., Vieira, A.D., Figueiredo, J.B., & Nastri, C.O. (2013). FSH replaced by low-dose hCG in the late follicular phase versus continued FSH for assisted reproductive techniques. Cochrane Database of Systematic Reviews, 2013, CD010042. doi: 10.1002/14651858.CD010042.pub2. .
   Web of Science ®Google Scholar
• Revelli, A., Casano, S., Salvagno, F., & Delle Piane, L. (2011). Milder is better? Advantages and disadvantages of “mild” ovarian stimulation for human in vitro fertilization. Reproductive Biology and Endocrinology, 9, 25. doi: 10.1186/1477-7827-9-25.
   PubMed Web of Science ®Google Scholar
• Serafini, P., Yadid, I., Motta, E.L., Alegretti, J.R., Fioravanti, J., & Coslovsky, M. (2006). Ovarian stimulation with daily late follicular phase administration of low-dose human chorionic gonadotropin for in vitro fertilization: a prospective, randomized trial. Fertility and Sterility, 86, 830–838. doi: 10.1016/j.fertnstert.2006.02.110.
   PubMed Web of Science ®Google Scholar
• Shima, K., Kitayama, S., & Nakano, R. (1987). Gonadotropin binding sites in human ovarian follicles and corpora lutea during the menstrual cycle. Obstetrics and Gynecology, 69, 800–806. Retrieved from: http://journals.lww.com/greenjournal/Abstract/1987/05000/Gonadotropin_Binding_Sites_in_Human_Ovarian.24.aspx.
   PubMed Web of Science ®Google Scholar
• Sullivan, M.W., Stewart-Akers, A., Krasnow, J.S., Berga, S.L., & Zeleznik, A.J. (1999). Ovarian responses in women to recombinant follicle-stimulating hormone and luteinizing hormone (LH): a role for LH in the final stages of follicular maturation. Journal of Clinical Endocrinology and Metabolism, 84, 228–232. doi: 10.1210/jcem.84.1.5389.
   PubMed Web of Science ®Google Scholar
• Suppinyopong, S., Choavaratana, R., & Karavakul, C. (2000). Correlation of oocyte morphology with fertilization rate and embryo quality after intracytoplasmic sperm injection. Journal of the Medical Association of Thailand, 83, 627–632. Retrieved from: http://www.jmatonline.com/index.php/jmat/article/view/4163.
   PubMedGoogle Scholar
• Takao, Y., Honda, T., Ueda, M., Hattori, N., Yamada, S., Maeda, M., … Wimalasena, J. (1997). Immunohistochemical localization of the LH/HCG receptor in human ovary: HCG enhances cell surface expression of LH/HCG receptor on luteinizing granulosa cells in vitro. Molecular Human Reproduction, 3, 569–578. doi: 10.1093/molehr/3.7.569.
   PubMed Web of Science ®Google Scholar
• Thompson, K.A., LaPolt, P.S., River, J., Henderson, G., Dahl, K.D., & Meldrum, D.R. (1995). Gonadotropin requirements of the developing follicle. Fertility and Sterility, 63, 273–276. doi: 10.1016/S0015-0282(16)57354-3.
   PubMed Web of Science ®Google Scholar
• Van Horne, A.K., Bates, G.W., Jr., Robinson, R.D., Arthur, N.J., & Propst, A.M. (2007). Recombinant follicle-stimulating hormone (rFSH) supplemented with low-dose human chorionic gonadotropin compared with rFSH alone for ovarian stimulation for in vitro fertilization. Fertility and Sterility, 88, 1010–1013. doi: 10.1016/j.fertnstert.2006.12.051.
   PubMed Web of Science ®Google Scholar
• Verberg, M.F., Macklon, N.S., Nargund, G., Frydman, R., Devroey, P., Broekmans, F.J., & Fauser, B.C. (2009). Mild ovarian stimulation for IVF. Human Reproduction Update, 15, 13–29. doi: 10.1093/humupd/dmn056.
   PubMed Web of Science ®Google Scholar
• Westergaard, L.G., Laursen, S.B., & Andersen, C.Y. (2000). Increased risk of early pregnancy loss by profound suppression of luteinizing hormone during ovarian stimulation in normogonadotrophic women undergoing assisted reproduction. Human Reproduction, 15, 1003–1008. doi: 10.1093/humrep/15.5.1003.
   PubMed Web of Science ®Google Scholar
• Wilding, M., Di Matteo, L., D'andretti, S., Montanaro, N., Capobianco, C., & Dale, B. (2007). An oocyte score for use in assisted reproduction. Journal of Assisted Reproduction and Genetics, 24, 350–358. doi: 10.1007/s10815-007-9143-8.
   PubMed Web of Science ®Google Scholar
• Wu, Z., Li, R., Ma, Y., Deng, B., Zhang, X., Meng, Y., … Qiao, J. (2012). Effect of HCG-day serum progesterone and oestradiol concentrations on pregnancy outcomes in GnRH agonist cycles. Reproductive Biomedicine Online, 24, 511–520. doi: 10.1016/j.rbmo.2012.02.003.
   PubMed Web of Science ®Google Scholar
• Xia, P. (1997). Intracytoplasmic sperm injection: correlation of oocyte grade based on polar body, perivitelline space and cytoplasmic inclusions with fertilization rate and embryo quality. Human Reproduction, 12, 1750–1755. doi: 10.1093/humrep/12.8.1750.
   PubMed Web of Science ®Google Scholar
• Xu, B., Li, Z., Zhang, H., Jin, L., Li, Y., Ai, J., & Zhu, G. (2012). Serum progesterone level effects on the outcome of in vitro fertilization in patients with different ovarian response: an analysis of more than 10,000 cycles. Fertility and Sterility, 97, 1321–1327.e4. doi: 10.1016/j.fertnstert.2012.03.014.
   PubMed Web of Science ®Google Scholar